Letrozole and Faslodex: what should you know?

Letrozole is taken by mouth and lowers the amount of estrogen made through aromatase. Faslodex, also called fulvestrant, is given as an injection into the muscle. It binds to estrogen receptors and helps reduce their signalling. Your oncologist chooses the combination based on your cancer features, previous treatment, overall health, and treatment goals.

Possible effects include hot flushes, sweating, tiredness, joint or muscle discomfort, nausea, reduced appetite, and injection-site pain or soreness. Letrozole can affect bone strength over time, while Faslodex may cause bruising or discomfort where it is injected.

Keep each injection appointment and take letrozole on the schedule provided. Bring a full list of medicines, vitamins, and supplements to every review. Tell the team about liver disease, bleeding problems, low blood counts, bone conditions, or a history of severe reactions to injections.

Plan simple support for fatigue, such as pacing activities and resting between tasks. Report symptoms early rather than changing doses yourself. The team may arrange examinations or blood tests to assess side effects and whether the treatment remains suitable.

Call your treatment team for worsening injection-site redness, warmth, swelling, or pain; unusual bleeding or bruising; severe abdominal pain; yellow skin or eyes; or persistent vomiting. Seek urgent care for sudden breathing difficulty, facial swelling, chest pain, fainting, or new one-sided weakness.

Ask what each medicine is intended to do, why they are being combined, how injection visits are arranged, which side effects need a same-day call, and how bone or liver health will be followed.